Land: Portugal
Språk: engelsk
Kilde: HMA (Heads of Medicines Agencies)
chlamydophila abortus (chlamydia psittaci var. ovis) 100000 IU
Intervet Intenational BV
QI04AE01
Powder and solvent for suspension for injection
Chlamydia vaccine
Sheep Females
2012-02-28
Ovilis Enzovax renew al (DE/V/0246/001/ R/001) Proposed SPC-labelling-leaflet 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Ovilis Enzovax Lyophilisate and solvent for suspension for injection for sheep 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Freeze-dried vaccine (per dose): ACTIVE SUBSTANCE : Live attenuated _Chlamydophila abortus_ strain ts 1B: 10 5.0 – 10 6.9 IFU IFU = inclusion-body forming units Diluent: Unisolve is supplied with the vaccine. EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate and solvent for suspension for injection. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Susceptible female breeding sheep 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of susceptible female breeding sheep as an aid in the prevention of abortion and stillbirth caused by _Chlamydophila abortus_ (previously referred to as _Chlamydia psittaci_) infection. Onset of immunity: vaccination 4 weeks before mating has shown that susceptible ewes are protected. Duration of immunity: 3-4 years (See also under re-vaccination policy 4.9.) 4.3 CONTRAINDICATIONS Do not vaccinate pregnant animals. Do not vaccinate animals less than 4 weeks before mating. Do not vaccinate animals which are being treated with antibiotics, particularly tetracyclines. 4.4 SPECIAL WARNINGS Ovilis Enzovax renew al (DE/V/0246/001/ R/001) Proposed SPC-labelling-leaflet _Chlamydophila abortus_ is only one of the causes of abortion in sheep. If the abortion rate remains unchanged in flocks which have been vaccinated with Ovilis Enzovax it is recommended that veterinary advice is sought. The Les hele dokumentet